Stay updated on Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a new Locations section with Massachusetts sites; removed the Massachusetts Locations subsection and the HHS Vulnerability Disclosure link, and updated the page version from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T17:20:58.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown replacing v3.2.0; this is a minor admin update with no changes to study content, eligibility criteria, outcomes, or contacts; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T20:54:08.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page; the banner previously informing visitors about potential delays and NIH operating status is no longer displayed. Core study details, eligibility criteria, and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:16:39.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The two screenshots show no substantive changes to the study data (title, conditions, eligibility, locations, enrollment, or outcomes), only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T12:53:09.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Updated page to v3.2.0 with a broad government-operating-status notice; removed a specific resource entry (Carcinoma of esophagus) from the Genetic and Rare Diseases Information Center, and retained general references to NIH/C cc and related sites.
    Difference
    3%
    Check dated 2025-10-05T17:28:48.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.1%
    Check dated 2025-09-28T10:46:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Refractory Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Refractory Esophageal Cancer Clinical Trial page.